Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$915M |
| 2 |
Meta Platforms (Facebook)
META
|
+$693M |
| 3 |
Salesforce
CRM
|
+$618M |
| 4 |
Walt Disney
DIS
|
+$559M |
| 5 |
Nike
NKE
|
+$545M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$1.51B |
| 2 |
Pfizer
PFE
|
+$1.43B |
| 3 |
UBS Group
UBS
|
+$588M |
| 4 |
HSBC
HSBC
|
+$537M |
| 5 |
Procter & Gamble
PG
|
+$439M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.07% |
| 2 | Consumer Discretionary | 10.99% |
| 3 | Financials | 10.93% |
| 4 | Healthcare | 10.39% |
| 5 | Communication Services | 6.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
iShares ESG Aware 1-5 Year USD Corporate Bond ETF
SUSB
$1.3B
| $2.68M | ﹤0.01% |
107,485
+3,229
| +3% | +$81.5K |
|
|
ALXN
377
DELISTED
Alexion Pharmaceuticals
ALXN
| $2.68M | ﹤0.01% |
29,822
+16,687
| +127% | +$1.64M |
|
378
Vanguard Total World Stock ETF
VT
$79.8B
| $2.58M | ﹤0.01% |
41,005
+3,900
| +11% | +$294K |
|
379
iShares Europe ETF
IEV
$1.7B
| $2.56M | ﹤0.01% |
72,437
-37,251
| -34% | -$1.58M |
|
380
Ross Stores
ROST
$81.9B
| $2.56M | ﹤0.01% |
29,420
-927
| -3% | -$99K |
|
381
Regeneron Pharmaceuticals
REGN
$80.8B
| $2.51M | ﹤0.01% |
5,143
-145
| -3% | -$59.8K |
|
382
Hexcel
HXL
$7.82B
| $2.45M | ﹤0.01% |
65,835
+13,664
| +26% | +$882K |
|
|
KYO
383
DELISTED
Kyocera Adr
KYO
| $2.39M | ﹤0.01% |
40,250
-25,589
| -39% | -$1.52M |
|
|
SFBS
384
ServisFirst Bancshares
SFBS
$4.86B
| $2.38M | ﹤0.01% |
81,198
-4,766
| -6% | -$167K |
|
385
Altria Group
MO
$114B
| $2.33M | ﹤0.01% |
60,373
+11,370
| +23% | +$505K |
|
|
RDS.B
386
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $2.33M | ﹤0.01% |
71,212
+9,653
| +16% | +$452K |
|
387
Illinois Tool Works
ITW
$84.5B
| $2.29M | ﹤0.01% |
16,093
+3,834
| +31% | +$651K |
|
388
Roper Technologies
ROP
$39.8B
| $2.28M | ﹤0.01% |
7,316
+1,308
| +22% | +$463K |
|
389
Vipshop
VIPS
$7.53B
| $2.28M | ﹤0.01% |
146,231
-69,490
| -32% | -$988K |
|
390
Cactus
WHD
$5.44B
| $2.26M | ﹤0.01% |
194,986
+41,161
| +27% | +$1.03M |
|
391
Verizon
VZ
$196B
| $2.25M | ﹤0.01% |
41,876
-3,281
| -7% | -$188K |
|
392
T. Rowe Price
TROW
$24.3B
| $2.2M | ﹤0.01% |
22,532
-877
| -4% | -$107K |
|
|
FARO
393
DELISTED
Faro Technologies
FARO
| $2.19M | ﹤0.01% |
49,160
-6,861
| -12% | -$356K |
|
394
AbbVie
ABBV
$435B
| $2.17M | ﹤0.01% |
28,484
-271,252
| -90% | -$23.1M |
|
395
Republic Services
RSG
$65.7B
| $2.15M | ﹤0.01% |
28,713
-1,150
| -4% | -$104K |
|
396
State Street SPDR S&P 500 ETF Trust
SPY
$823B
| $2.13M | ﹤0.01% |
8,260
-852
| -9% | -$260K |
|
397
Comfort Systems
FIX
$59.6B
| $2.1M | ﹤0.01% |
57,585
-4,061
| -7% | -$180K |
|
398
Genpact
G
$5.76B
| $2.1M | ﹤0.01% |
71,922
+1,523
| +2% | +$59.6K |
|
399
IBM
IBM
$224B
| $2.06M | ﹤0.01% |
19,399
-1,295
| -6% | -$164K |
|
400
State Street Financial Select Sector SPDR ETF
XLF
$58.2B
| $2.06M | ﹤0.01% |
98,778
+25,251
| +34% | +$695K |
|
Similar funds
Ken Fisher's Q1 2020 Portfolio in Review
As of Q1 2020, Ken Fisher held 982 positions worth $80.6B, down 19% from $99B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Fisher's Q1 2020 filing shows 84 new, 262 increased, 421 reduced and 116 closed positions. Its largest new stake was Advanced Micro Devices: 7,132,669 shares worth $324M. The largest sale was Johnson & Johnson, an estimated $1.51B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
- Ken Fisher's largest Q1 2020 buy was Advanced Micro Devices: 7,132,669 shares worth $324M.
- Ken Fisher added most to Mastercard in Q1 2020, an estimated $915M increase.
- Ken Fisher's biggest Q1 2020 reduction was Johnson & Johnson, cutting an estimated $1.51B.
- Ken Fisher fully exited Ambev in Q1 2020, selling an estimated $89.9M.
- Ken Fisher's ten largest holdings make up 31% of its $80.6B portfolio in Q1 2020.
- Ken Fisher opened 84 new positions and closed 116 in Q1 2020.
- Ken Fisher's portfolio value fell 19% quarter-over-quarter to $80.6B.
Based on Fisher Asset Management's 13F filing for Q1 2020, filed 28 Apr 2020.